NOVN · Novartis AG
125.60
EURUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Euro254.86B
PE
18.40
EV/EBITDA
12.7
DIV Yield
3.4%
Payout Ratio
62%
MQV Rating
5Very Weak
As at 02/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
Key Fundamentals
EPS 3 yr Growth
110.60%
EBITDA Margin
40.90%
Operating Cashflow
€16,963m
Free Cash Flow Return
26.30%
ROIC
19.20%
Interest Coverage
18.90
Quick Ratio
0.90
Performance
52 weeks range
Low 105.34 - 141.5
Trade Value (12mth)
US$273.00
1 week
-4.49%
1 month
-9.3%
YTD
8.76%
1 year
0%
All time high
141.50
Additional Data
Shares Outstanding (Fully Diluted)
1,914m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
10-Mar-26
Next Dividend Pay Date
12-Mar-26
Reporting Currency
EUR
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
Key Stakeholders
| Name | Title |
| Novartis AG | Public Company |
| Sandoz Family Foundation | Foundation/Endowment |
| Hans Jörg Reinhardt | Individual |
| Ton Büchner | Individual |
| Frans van Houten | Individual |
